Delta4
Click to visit website
About
Delta4 is a specialized TechBio company that leverages artificial intelligence and systems biology to revolutionize the drug discovery process. Its primary mission is to help pharmaceutical and biotechnology companies expand the indications for drugs that already possess established safety profiles. By focusing on drug repurposing and indication expansion, the platform enables organizations to bypass many of the initial risks associated with early-stage drug development, significantly shortening the timeline for bringing new treatments to patients. This approach focuses on efficiency and safety by building upon clinical data that has already been verified in human subjects. At the core of Delta4’s offering is Hyper-C, a proprietary AI-powered software platform. This technology integrates large-scale biological data with computational modeling to simulate and predict drug behavior in silico. The platform is operated by a dedicated team of computational biologists who analyze complex disease mechanisms and detect previously undetected relationships between known drugs and potential new therapeutic targets. This data-driven approach allows for high precision and speed in uncovering new opportunities that traditional lab-based methods might overlook, making it possible to identify potential treatments for complex conditions like Long COVID. The service is specifically designed for R&D teams in the pharmaceutical industry, academic research institutions, and biotech startups. By providing detailed in-silico models and predictive insights, Delta4 helps these stakeholders reduce the high costs and failure rates typically associated with clinical trials. The tool is particularly effective for organizations looking to breathe new life into existing assets or those focused on specialized areas where understanding intricate biological networks is crucial for therapeutic success. What distinguishes Delta4 from generic AI discovery tools is its deep integration of systems biology with human expertise. Unlike purely automated solutions, Delta4 emphasizes a collaborative process where AI-generated insights are refined by subject matter experts. Furthermore, its membership in frameworks like Scientist.com ensures a streamlined and transparent collaboration process, making it a reliable partner for global pharmaceutical giants and top-tier medical universities. The company maintains an active presence in the scientific community, regularly publishing research on Proof of Concept clinical trials and innovative drug development strategies.
Pros & Cons
Focuses on drugs with known safety profiles to significantly reduce clinical risk.
Proprietary Hyper-C platform offers high-speed computational modeling and precision.
Established partnerships with major industry players like Takeda and Biogen.
Streamlined procurement and legal transparency through Scientist.com membership.
Combines automated AI processing with human-expert computational biology analysis.
Pricing is not publicly disclosed and requires a custom quote via direct contact.
The tool is specialized for existing drug expansion rather than de novo molecule design.
Highly technical data outputs require specialized biological knowledge to interpret.
Use Cases
Pharmaceutical R&D heads can use Hyper-C to identify new therapeutic uses for existing compounds, maximizing the ROI of their current asset portfolio.
Biotech startups can leverage in-silico modeling to validate potential drug targets before committing to expensive and risky physical clinical trials.
Academic researchers can partner with the computational biology team to map complex disease mechanisms for conditions like Long COVID.
Clinical trial managers can utilize predictive data to design more focused and safer Proof of Concept (PoC) studies.
Therapeutic developers can use the platform to identify undetected relationships between known safety-profile drugs and rare disease indications.
Platform
Task
Features
• scientist.com collaboration framework
• computational biology expert consultation
• large-scale biological data analysis
• disease mechanism mapping
• drug indication expansion identification
• systems biology computational modeling
• in-silico drug behavior prediction
• hyper-c ai software platform
FAQs
What is the primary focus of Delta4's technology?
Delta4 focuses on indication expansion, using its Hyper-C platform to find new therapeutic uses for existing drugs with known safety profiles. This reduces the time and risk associated with traditional drug development.
What is the Hyper-C platform?
Hyper-C is a proprietary AI-powered software platform that combines systems biology and computational modeling to predict drug behavior in silico. It allows researchers to detect relationships between drugs and diseases with high accuracy.
How does Delta4 ensure the quality of its AI-driven insights?
The Hyper-C platform is operated by a team of highly skilled computational biologists. They manually analyze the data outputs to produce unique insights and validate drug indication expansion opportunities.
Does Delta4 offer partnership opportunities?
Yes, Delta4 offers collaborations on research, co-development, and consortia projects. They work with pharmaceutical companies, biotech firms, and academic institutions globally.
How does Delta4 streamline the procurement process for its services?
Delta4 is a member of Scientist.com, which provides a platform for streamlining transparency and cooperation. This framework simplifies the process of defining terms and conditions for agreements.
Can Delta4 assist with Proof of Concept (PoC) clinical trials?
The platform provides predictive data and in-silico models that help inform and accelerate early Phase II clinical studies. This helps researchers answer fundamental questions about drug efficacy before full-scale trials.
Job Opportunities
EU-funded computational biology PhD position (Prostate Research)
Identify new therapeutic indications for existing compounds using an AI-powered systems biology platform to reduce R&D costs and accelerate time-to-market.
Education Requirements:
PhD candidate
Other Requirements:
EU-funded
Responsibilities:
Prostate Research
Computational biology
Show more details
EU-funded computational biology PhD position (Kidney Research)
Identify new therapeutic indications for existing compounds using an AI-powered systems biology platform to reduce R&D costs and accelerate time-to-market.
Education Requirements:
PhD candidate
Other Requirements:
EU-funded
Responsibilities:
Kidney Research
Computational biology
Show more details
Ratings & Reviews
No ratings available yet. Be the first to rate this tool!
Alternatives
X-Chem
Identify high-quality drug leads and optimize clinical candidates using DNA-encoded library data and Chemomics to reduce risk in biotech and pharma discovery.
View Details
BenevolentAI
Uncover new therapeutic insights and accelerate drug discovery with AI-driven life science intelligence designed for researchers and pharmaceutical teams.
View Details
Aitia Bio
Aitia Bio uses AI, multi-omic data, and Gemini Digital Twins to accelerate drug discovery and development, focusing on oncology and neurodegenerative diseases.
View Details
Aganitha AI
Aganitha AI is an in silico company that partners with biopharma, personal & homecare, and material sciences industries, leveraging AI to accelerate scientific R&D.
View Details
MindRank
Accelerate small molecule drug discovery and tackle hard-to-drug targets using a clinical-stage AI platform designed for biotech and pharmaceutical researchers.
View Details
ALS.ai
Accelerate ALS drug discovery and target identification using deep generative models and multi-omics data analysis to find novel therapeutics for patients.
View Details
canSAR.ai
canSAR.ai is an integrated knowledge-base leveraging machine learning and AI for cancer drug discovery and translational research worldwide.
View Details
Phenomic AI
Identify novel therapeutic targets for hard-to-treat solid tumors by using an ML-powered transcriptomics platform to analyze single-cell RNA and stromal biology.
View Details
biotx.ai
Help pharmaceutical researchers accelerate drug discovery and minimize clinical trial failure by mapping causal genetic links using AI-driven Mendelian randomization.
View Details
Proxima
Design programmable protein interactions and discover next-generation proximity-based medicines using an integrated AI platform for biopharmaceutical research.
View Details
Iktos
Accelerate drug discovery by integrating generative AI with automated robotics to design, synthesize, and test novel molecules in under two years for pharma teams.
View Details
Atomic AI
Accelerate RNA drug discovery using a foundation model that predicts 3D structures with atomic precision to unlock previously inaccessible therapeutic targets.
View Details
Iambic
Design superior therapeutic molecules and accelerate drug discovery using physics-based AI algorithms and high-throughput experimental feedback loops.
View Details
GSK.ai
Accelerate drug discovery and vaccine development by leveraging AI to interpret complex genetic datasets and understand the fundamental language of human cells.
View Details
Cognit
Accelerate functional genomics research and simulate complex gene regulatory networks using cross-species foundational AI models for in-silico cell engineering.
View Details
Gero
Extend healthy human lifespan and discover novel therapeutic targets using physics-informed AI models trained on over 100 million longitudinal medical records.
View Details
Receptor.AI
Optimize early-stage drug discovery for biotech researchers using an AI ecosystem that identifies cryptic binding sites and predicts over 80 ADMET endpoints.
View Details
Wisecube
Accelerate life sciences R&D using a foundational graph AI that unifies billions of biomedical data points to provide reliable, literature-backed insights.
View Details
Pending AI
Empower drug discovery teams to unlock difficult-to-drug targets and optimize lead candidates using quantum mechanical precision and trillion-scale generative AI.
View DetailsFeatured Tools
adly.news
Connect with engaged niche audiences or monetize your subscriber base through an automated marketplace featuring verified metrics and secure Stripe payments.
View Details
Atoms
Launch full-stack products and acquire customers in minutes using a coordinated team of AI agents that handle everything from deep research to SEO and coding.
View Details
Sketch To
Convert images into artistic sketches or transform hand-drawn drafts into realistic photos using advanced AI models designed for artists, designers, and hobbyists.
View Details
Seedance 4.0
Create high-definition AI videos from text prompts or images in seconds with built-in audio, commercial rights, and support for multiple cinematic models.
View Details
Seedance
Transform text prompts or static images into cinematic 1080p videos with fluid motion and consistent multi-shot storytelling for creators and brands.
View Details
GenMix
Generate professional-quality AI videos, images, and voiceovers using world-class models like Sora 2 and Kling 2.6 through a single, unified creative dashboard.
View Details